IB
EW icon

Intrust Bank’s Edwards Lifesciences EW Stock Holding History

Intrust Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
14,333
+478
+3% +$39.4K 0.09% 151
2025
Q4 		$1.18M Buy
13,855
+600
+5% +$49.2K 0.1% 144
2025
Q3 		$1.03M Sell
13,255
-500
-4% -$39.1K 0.09% 162
2025
Q2 		$1.08M Buy
13,755
+1,991
+17% +$148K 0.1% 150
2025
Q1 		$853K Buy
11,764
+1,182
+11% +$84.6K 0.08% 166
2024
Q4 		$783K Sell
10,582
-1,741
-14% -$122K 0.08% 181
2024
Q3 		$813K Sell
12,323
-2,676
-18% -$194K 0.08% 179
2024
Q2 		$1.39M Sell
14,999
-30
-0.2% -$2.66K 0.15% 117
2024
Q1 		$1.44M Sell
15,029
-683
-4% -$57.4K 0.15% 118
2023
Q4 		$1.2M Sell
15,712
-1,176
-7% -$81.8K 0.14% 129
2023
Q3 		$1.17M Sell
16,888
-512
-3% -$41.1K 0.15% 123
2023
Q2 		$1.64M Sell
17,400
-799
-4% -$69.4K 0.2% 94
2023
Q1 		$1.51M Buy
18,199
+1,914
+12% +$150K 0.19% 104
2022
Q4 		$1.22M Sell
16,285
-1,066
-6% -$82.2K 0.17% 114
2022
Q3 		$1.43M Sell
17,351
-1
-0% -$96 0.22% 88
2022
Q2 		$1.65M Sell
17,352
-1,891
-10% -$196K 0.24% 84
2022
Q1 		$2.27M Buy
19,243
+14
+0.1% +$1.57K 0.29% 65
2021
Q4 		$2.49M Sell
19,229
-52
-0.3% -$6.07K 0.3% 58
2021
Q3 		$2.18M Sell
19,281
-279
-1% -$31.8K 0.29% 66
2021
Q2 		$2.03M Sell
19,560
-647
-3% -$61K 0.27% 73
2021
Q1 		$1.69M Sell
20,207
-751
-4% -$63.5K 0.24% 82
2020
Q4 		$1.91M Buy
20,958
+86
+0.4% +$7.13K 0.29% 72
2020
Q3 		$1.67M Sell
20,872
-668
-3% -$52.1K 0.3% 70
2020
Q2 		$1.49M Buy
21,540
+1,740
+9% +$124K 0.3% 73
2020
Q1 		$1.25M Sell
19,800
-246
-1% -$17.7K 0.35% 68
2019
Q4 		$1.56M Buy
20,046
+165
+0.8% +$12.9K 0.36% 65
2019
Q3 		$1.46M Sell
19,881
-483
-2% -$33.9K 0.37% 63
2019
Q2 		$1.25M Buy
20,364
+312
+2% +$18.9K 0.31% 79
2019
Q1 		$1.28M Buy
20,052
+537
+3% +$30.6K 0.33% 69
2018
Q4 		$996K Buy
19,515
+1,128
+6% +$57.1K 0.29% 78
2018
Q3 		$1.07M Sell
18,387
-1,170
-6% -$57.2K 0.27% 86
2018
Q2 		$949K Buy
19,557
+531
+3% +$24.8K 0.26% 92
2018
Q1 		$885K Buy
19,026
+366
+2% +$15.9K 0.26% 97
2017
Q4 		$701K Sell
18,660
-342
-2% -$12.6K 0.21% 136
2017
Q3 		$693K Buy
19,002
+213
+1% +$8.12K 0.23% 134
2017
Q2 		$741K Buy
18,789
+2,037
+12% +$74.4K 0.25% 110
2017
Q1 		$525K Buy
16,752
+1,695
+11% +$53.1K 0.19% 156
2016
Q4 		$471K Buy
15,057
+885
+6% +$28.7K 0.18% 175
2016
Q3 		$570K Buy
14,172
+1,782
+14% +$67.1K 0.23% 138
2016
Q2 		$412K Sell
12,390
-4,578
-27% -$157K 0.17% 194
2016
Q1 		$499K Buy
16,968
+2,400
+16% +$66.2K 0.18% 164
2015
Q4 		$384K Buy
14,568
+5,550
+62% +$144K 0.14% 183
2015
Q3 		$214K Buy
+9,018
New +$218K 0.08% 245

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Intrust Bank's EW Position: Q1 2026 in Review

Intrust Bank increased its Edwards Lifesciences (EW) stake by 3.5% in Q1 2026, buying an estimated $39.4K and bringing the position to 14,333 shares worth $1.15M. The position accounts for 0.09% of the portfolio, ranked #151.

Intrust Bank first reported a position in EW in Q3 2015 and has held it in 43 quarters since. The position peaked at $2.49M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Intrust Bank held 14,333 shares of Edwards Lifesciences worth $1.15M as of Q1 2026.
  • Intrust Bank bought 478 Edwards Lifesciences shares in Q1 2026, an estimated $39.4K.
  • Edwards Lifesciences made up 0.09% of Intrust Bank's portfolio in Q1 2026, its #151 holding.
  • Intrust Bank first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 43 quarters since.
  • Intrust Bank's Edwards Lifesciences position peaked at $2.49M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.